Diphtheria Pipeline Review, H1 2018 - Analysis by Stage of Development, Drug Target, Mechanism of Action, Route of Administration and Molecule Type - ResearchAndMarkets.com

DUBLIN--()--The "Diphtheria - Pipeline Review, H1 2018" report has been added to ResearchAndMarkets.com's offering.

This latest pipeline guide provides comprehensive information on the therapeutics under development for Diphtheria (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.

The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Diphtheria (Infectious Disease) pipeline guide also reviews key players involved in therapeutic development for Diphtheria and features dormant and discontinued projects.

The guide covers therapeutics under Development by Companies/Universities/Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, IND/CTA Filed and Preclinical stages are 2, 1, 7, 4, 3, 2 and 8 respectively. Similarly, the Universities portfolio in Phase II, Preclinical and Discovery stages comprises 1, 1 and 1 molecules, respectively.

Key Topics Covered

  1. Introduction
  2. Report Coverage
  3. Diphtheria - Overview
  4. Diphtheria - Therapeutics Development
  5. Pipeline Overview
  6. Pipeline by Companies
  7. Pipeline by Universities/Institutes
  8. Products under Development by Companies
  9. Products under Development by Universities/Institutes
  10. Diphtheria - Therapeutics Assessment
  11. Assessment by Target
  12. Assessment by Route of Administration
  13. Assessment by Molecule Type
  14. Diphtheria - Companies Involved in Therapeutics Development

Companies Mentioned

  • Beijing Minhai Biotechnology Co Ltd
  • Biological E Ltd
  • Boryung Pharmaceutical Co Ltd
  • Cadila Healthcare Ltd
  • Chongqing Zhifei Biological Products Co Ltd
  • GC Pharma
  • GlaxoSmithKline Plc
  • Indian Immunologicals Ltd
  • Kaketsuken
  • LG Chem Ltd
  • Panacea Biotec Ltd
  • Sanofi
  • Sanofi Pasteur SA
  • Serum Institute of India Ltd
  • Shantha Biotechnics Pvt Ltd
  • Wockhardt Ltd

For more information about this report visit https://www.researchandmarkets.com/research/jjlmgg/diphtheria?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Infectious Diseases Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Infectious Diseases Drugs